about
Long-acting insulin analogue versus another long-acting insulin analogue for type 2 diabetes mellitusOne-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trialDose accuracy of a reusable insulin pen using a cartridge system with an integrated plunger mechanism.An information and communication technology-based centralized clinical trial to determine the efficacy and safety of insulin dose adjustment education based on a smartphone personal health record application: a randomized controlled trial.Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study.Predictors of initiating rapid-acting insulin analog using vial/syringe, prefilled pen, and reusable pen devices in patients with type 2 diabetes.A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes.Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled type 2 diabetes in the United KingdomSafety and efficacy of modern insulin analogues.Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1).Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L)Insulin initiation in type 2 diabetes: what are the treatment regimen options and how can we best help patients feel empowered?New Insulin Glargine 300 U/mL for the Treatment of Type 1 and Type 2 Diabetes Mellitus.Preparation, in vitro release, in vivo absorption and biocompatibility studies of insulin-loaded microspheres in rabbitsLiraglutide reverses pronounced insulin-associated weight gain, improves glycaemic control and decreases insulin dose in patients with type 2 diabetes: a 26 week, randomised clinical trial (ELEGANT).
P2860
Q24243694-9D884E1F-53CD-46C8-B4E7-CB59DF6ABFBCQ24656644-AD7BD5C3-24D1-48A7-AEFF-1FDDFDDE835DQ33256110-A03D3020-9F2D-4BE4-AF3E-49124AE899E7Q33455660-26822EE3-F8D0-4D73-B2A0-817440103BD2Q33606579-E82E87E6-8FA4-4307-A6C7-FB4E86C3485AQ33979653-1D4539C7-7AAF-4A8D-83BC-59425D1E2D5FQ36449523-CC5CF7B5-5DD4-4D07-953A-B5C2EC28CECBQ36897192-0F105DD1-16B0-4F84-B2D2-F52B3D10FE2BQ36945452-0B327661-BF2C-40A3-A4CA-E70BA369D460Q37106467-8F793D44-EB25-4A2C-B4CE-575CEC7D9620Q37106537-A4CA7F55-C7BA-4CA8-8E69-C4AA1C1614B3Q38008005-88975825-0A4D-4D26-824B-AAC9962DF3CDQ38559945-9220D5B7-B020-478E-92DF-EAC4238D8F51Q41846020-D409F75E-94DF-4E42-9C62-DA6CB14C2486Q47579611-CABCE9DE-2164-47B1-AAE5-B00E32B716DF
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Timely initiation of basal insulin.
@ast
Timely initiation of basal insulin.
@en
type
label
Timely initiation of basal insulin.
@ast
Timely initiation of basal insulin.
@en
prefLabel
Timely initiation of basal insulin.
@ast
Timely initiation of basal insulin.
@en
P1476
Timely initiation of basal insulin.
@en
P2093
Matthew C Riddle
P356
10.1016/J.AMJMED.2003.12.003
P407
P478
116 Suppl 3A
P577
2004-02-01T00:00:00Z